Seminars in radiation oncology
July 1, 2026
Hanna S W Conradi, Jamie N Petersson, Julie M Deleemans et al.
1 citation
Many people with cancer (PWC) continue to experience persistent biopsychosocial and existential challenges across the cancer care continuum. Symptoms such as anxiety, depression, cancer-related fatigue and pain, sleep disturbance, fear of cancer recurrence, cognitive impairment, and reduced quality of life remain highly prevalent during and after treatment, underscoring the need for...
2026
Juliana Mendes Rocha, Elisabeth Tove Irving, Evan Forth et al.
preprint
Introduction Psychedelic assisted therapy has gained increasing clinical and research attention in the last decade due to its demonstrated therapeutic potential across a variety of complex and treatment-resistant psychiatric and psychosocial conditions. As interest grows, so has the development of facilitator education and training programs. Despite this proliferation, concerns remain regarding...
Global Advances in Integrative Medicine and Health
2026
Haley D M Schuman, Raèf Mina, Sofia Barkova et al.
Healthcare providers' (HCPs) perspectives on psychedelic-assisted therapy (PAT) are critical to clinical integration but remain underexplored in Canadian palliative and oncology contexts. This study examines HCP attitudes toward ketamine, psilocybin, and MDMA, and the systemic and ethical factors influencing implementation. An exploratory qualitative study using semi-structured interviews was...
Current Oncology
December 22, 2025
Linda E. Carlson, Harriet Richardson, Ron Shore et al.
1 citation
The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) was launched in 2025 to address urgent gaps in supportive care for Canadians with cancer experiencing demoralization syndrome (loss of meaning, dysphoria, disheartenment, helplessness, a sense of failure) and related psychosocial distress. CAN-PACT has six major objectives: (1) to develop a national interdisciplinary...
Research Square
August 19, 2025
Haley D M Schuman, Julie M Deleemans, Tina Nguyen et al.
preprint
Abstract Background Psychedelic-assisted therapy (PAT) is gaining attention as a potential treatment for cancer-related psychosocial symptoms. While growing evidence highlights its promise, little is known about how different stakeholder groups perceive its use in oncology and palliative care. Objectives This study aimed to assess stakeholder-specific perspectives on PAT, including attitudes,...
Current Oncology
June 30, 2025
Haley D M Schuman, Chantal Savard, Raèf Mina et al.
9 citations
This systematic review and meta-analysis evaluates (1) the effectiveness of psychedelic-assisted therapy (PAT) using psilocybin and ketamine for psychosocial symptoms in adults with cancer, (2) contextualizes findings with non-randomized and exploratory studies of other psychedelics, and (3) examines the role of therapeutic frameworks in shaping outcomes. We searched PubMed, Cochrane Library,...
Integrative Cancer Therapies
2025
Haley D M Schuman, Sofia Barkova, Raèf Mina et al.
2 citations
People living with cancer (PLWC) often face profound existential distress that is insufficiently addressed by conventional psychosocial supports. This qualitative study explored PLWC's attitudes, beliefs, and experiences regarding psychedelic-assisted therapy (PAT) as a novel approach to addressing psychosocial suffering, particularly existential distress. Fifteen participants with varying...